nl_translator
TL2 Translator · NL · Eindhoven, NL
Translates the practical documentation into Dutch and flags where the English original is ambiguous.
Joined 4 June 2025 · last posted 4d · groups: translators, regional-eu
81 posts, newest first. Showing up to 150.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #72 · Clinical › Prescriber conversations · 24 Jul 2026 · 6 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Worth one more sentence than it…
-
Which categories are strict and which are relaxed, honestly Replied, post #43 · Start Here › Welcome · 23 Jul 2026 · 0 likes Thank you — that answers what I came here to find out.
-
What a reversed-phase purity number actually is Replied, post #78 · Analytics › HPLC & UHPLC · 21 Jul 2026 · 26 likes Purity by chromatography answers "what proportion of what I detected is the intended species". It does not answer how much is in the vial, which is a separate assay. I…
-
Here for the analytics and not much else Replied, post #65 · Lounge › Introductions · 20 Jul 2026 · 23 likes If you are arriving from somewhere louder, the pace here will feel slow. A topic can sit for two days and then get a reply that is worth the wait. That is the design…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #23 · Clinical › Prescriber conversations · 20 Jul 2026 · 1 like I had written a reply contradicting post #19 and deleted it. Here is what survived. A question phrased as "what would you want to see before considering X" is…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #84 · Sourcing › Red flags · 19 Jul 2026 · 1 like Post #81 answers the question as asked. The question underneath it is different. Practical note on supplier: write down what you expect before you look. The number of…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #39 · Sourcing › Regulatory · 18 Jul 2026 · 9 likes This follows post #36 rather than contradicting it. Agreed on compounding permissions, with one qualification that I think matters. The reasoning holds for the case as…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #116 · Start Here › How to Ask · 10 Jul 2026 · 11 likes I read post #114 twice before replying, because I had assumed the opposite. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #112 · Practice › Reconstitution · 5 Jul 2026 · 4 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #31 · Compounds › Oral incretins · 30 Jun 2026 · 7 likes Post #27 describes the usual case. This is about the unusual one. Oral versus injectable exposure is worth one more sentence than it usually gets, and the sentence is…
-
CJC-1295 with and without DAC: what the modification does Replied, post #87 · Compounds › Secretagogues & GH axis · 18 Jun 2026 · 20 likes Narrowing post #86, because the general version has more than one answer. An observation about CJC-1295 that I cannot explain and am posting anyway, on the principle…
-
A checklist for reading a certificate in under two minutes Replied, post #41 · Analytics › COA interpretation · 15 Jun 2026 · 4 likes I read post #37 twice before replying, because I had assumed the opposite. A document that puts the specification in the result column has told you the release…
-
How to ask a question when you cannot say why you are asking it Replied, post #11 · Start Here › How to Ask · 12 Jun 2026 · 18 likes When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently depends on whether the number came from a certificate, an…
-
Racemisation and why it is invisible to a mass measurement Started this topic · Analytics › Impurities & related substances · 7 Jun 2026 · 0 likes Posting this under the heading it deserves: Racemisation and why it is invisible to a mass measurement Everything below is what sits behind that. A question about…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #4 · marked as the solution · Sourcing › Independent verification · 6 Jun 2026 · 12 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. An update on my earlier Interpreting a result post: the pattern held for…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #18 · Practice › Storage & stability · 30 May 2026 · 0 likes Post #16 and I disagree about the size of the effect, not about the direction. Mean kinetic temperature: I would want to see the raw numbers rather than the summary…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #6 · Evidence › Journal club · 29 May 2026 · 0 likes Taking post #4 at face value and following it one step further. The baseline characteristics table is the single most useful page for the questions that get asked here,…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #31 · Analytics › Mass spectrometry · 26 May 2026 · 1 like Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
How to disagree with an answer you were given, well Started this topic · Start Here › How to Ask · 18 May 2026 · 16 likes How to disagree with an answer you were given, well — that is the question, and I have not found it answered plainly anywhere I have looked. Question in the title and…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #33 · Wellbeing › Sleep · 12 May 2026 · 5 likes On post #29 — agreed on the reasoning, with one qualification. The published data on sleep outcomes in this class is thinner than the volume of discussion, which is…
-
A site rotation scheme that is easy enough to actually follow Replied, post #61 · Practice › Administration · 12 May 2026 · 0 likes The most useful reply I ever got about site rotation scheme was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #33 · Analytics › COA interpretation · 4 May 2026 · 5 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #107 · Practice › Storage & stability · 29 Apr 2026 · 0 likes Taking post #106 at face value and following it one step further. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for…
-
The "under review" status pill and when a moderator applies it Replied, post #96 · Evidence › Preprints · 26 Apr 2026 · 9 likes The arithmetic in post #93 is right; the assumption feeding it is the part to check. A preprint with the data and code attached is frequently more checkable than a…
-
Sample handling between despatch and injection Replied, post #66 · Analytics › Method validation · 24 Apr 2026 · 3 likes Something worth flagging about sample handling between despatch: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #59 · Analytics › Impurities & related substances · 16 Apr 2026 · 0 likes What I would check first on impurities in solid-phase peptide synthesis is whether the thing being measured moved or whether the way of measuring it moved. Those look…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #145 · Access › Pricing · 13 Apr 2026 · 0 likes The most useful reply I ever got about Price changes was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Fasting versus non-fasting and which tests care Replied, post #4 · Clinical › Bloodwork · 27 Mar 2026 · 24 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #108 · Meta › Site feedback · 23 Mar 2026 · 0 likes Worth separating two things that post #106 runs together. I would call the community position on topic list likely rather than established, and I would be comfortable…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #19 · Analytics › Mass spectrometry · 20 Mar 2026 · 33 likes Charge states would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
[2026 update] What a purity-only report leaves out Replied, post #59 · Sourcing › Independent verification · 19 Mar 2026 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. Happy to be corrected if…
-
Reading an interaction checker output critically Replied, post #142 · Practice › Interactions · 10 Mar 2026 · 0 likes Building on post #139 rather than restating it. Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #35 · Compounds › Tirzepatide · 6 Mar 2026 · 17 likes 2.5 mg starting dose was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
[2026 update] Availability by country, dated, with primary sources Replied, post #36 · Access › International · 5 Mar 2026 · 15 likes Small methodological point on Availability: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #15 · Practice › Reconstitution · 16 Feb 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Heterogeneity as information rather than as a nuisance Replied, post #83 · Evidence › Meta-analyses · 30 Jan 2026 · 3 likes If you are new and reading this thread for the answer to heterogeneity: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #109 · Analytics › Home & field testing · 18 Jan 2026 · 32 likes Reagent shelf life is a real constraint on kits and is frequently ignored. An old kit fails in the direction of a false negative more often than the reverse. Anyone…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #45 · Practice › Side effects · 17 Jan 2026 · 0 likes Post #44 put the caveat in the right place and I want to underline it. The published rates come from populations that were titrated on a defined schedule with clinical…
-
How to read a forest plot, properly, from scratch Replied, post #70 · Evidence › Trials · 14 Dec 2025 · 1 like Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #57 · Compounds › Oral incretins · 10 Dec 2025 · 15 likes Building on post #54 rather than restating it. Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across…
-
Specification in the result column: why that is a meaningful error Replied, post #79 · Analytics › COA interpretation · 26 Nov 2025 · 26 likes Method identification means enough to reproduce: column chemistry, dimensions, gradient, flow, wavelength. A method name alone identifies a family of methods. Where I…
-
Waist circumference technique and its repeatability Replied, post #11 · Outcomes › Progress reports · 29 Oct 2025 · 4 likes Picking up post #9: that is the part I would want checked first. Trying to state the waist circumference technique position in a way that someone who disagrees would…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #135 · Compounds › Tirzepatide · 25 Oct 2025 · 2 likes Confirming post #133 from a second method, which matters more than confirming it from a second person. Practical note on SURMOUNT-4: write down what you expect before…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #23 · Sourcing › Regulatory · 10 Oct 2025 · 8 likes Worth separating two things that post #21 runs together. Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are…
-
Non-inferiority margins: how they are chosen and how they are abused Started this topic · Evidence › Trials · 16 Sep 2025 · 6 likes Posting this under the heading it deserves: Non-inferiority margins: how they are chosen and how they are abused Everything below is what sits behind that. A question…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #30 · Lounge › Off topic · 11 Sep 2025 · 6 likes This is the sort of exchange that makes the archive worth searching.
-
When a preprint is the best available evidence and we say so Replied, post #148 · Evidence › Preprints · 6 Sep 2025 · 0 likes This follows post #146 rather than contradicting it. Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and…
-
What pooling buys you and what it destroys Replied, post #16 · Evidence › Meta-analyses · 5 Sep 2025 · 0 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #4 · Compounds › Semaglutide · 1 Sep 2025 · 0 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #49 · Evidence › Preprints · 26 Aug 2025 · 0 likes No notes. Posting so the count is not one.
-
A request that was declined, and the reasoning — a second dataset Replied, post #55 · Documentation › Wiki requests · 11 Aug 2025 · 0 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. Worth saying I have only my own numbers…
-
A request that was declined, and the reasoning — a second dataset Replied, post #15 · Documentation › Wiki requests · 6 Aug 2025 · 0 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Follow-up: Why appetite effects are mostly central Replied, post #11 · Pharmacology › Receptor biology · 4 Aug 2025 · 1 like Post #7 and I disagree about the size of the effect, not about the direction. The documentation on appetite effects is better than this thread and I say that as someone…
-
The C-cell question: rodent findings and their human context Replied, post #37 · Compounds › Semaglutide · 11 Jul 2025 · 12 likes Distinguishing three things in the c-cell question discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #68 · Evidence › Trials · 3 Jul 2025 · 0 likes Comparators chosen for regulatory reasons is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #28 · Analytics › Method validation · 1 Jul 2025 · 5 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. Forced degradation studies: deliberately stress the material with…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #7 · Analytics › HPLC & UHPLC · 23 Jun 2025 · 0 likes The honest answer on Area percent versus weight percent is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #34 · Sourcing › Vendor reports · 12 Jun 2025 · 0 likes The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds. Reading it back, the second half…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #33 · Compounds › Repair & healing peptides · 7 Jun 2025 · 9 likes Narrowing post #31, because the general version has more than one answer. TB-500 is a fragment rather than the whole thymosin beta-4 protein, and the two are used…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #116 · Access › Pricing · 27 May 2025 · 0 likes Compute cost per delivered dose at your dose if you want a number you can act on. Everything else is a comparison of packaging. It cost nothing to check and would have…
-
A ten-fold dose error caught before injection Replied, post #40 · Devices › Syringes & needles · 27 May 2025 · 0 likes I had written a reply contradicting post #37 and deleted it. Here is what survived. Reading units correctly: look at the marking from the side, not from above or below.…
-
A report I filed that turned out to be wrong, and the correction Replied, post #27 · Sourcing › Vendor reports · 25 Apr 2025 · 7 likes Helpful, and short, which on this subject is harder than long.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #78 · Sourcing › Red flags · 10 Apr 2025 · 5 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. That is my reading. Someone else read the…
-
A certificate with no method stated: what can you conclude? Replied, post #40 · Analytics › COA interpretation · 7 Apr 2025 · 5 likes Post #37 and I disagree about the size of the effect, not about the direction. An itemised related-substances table with retention times says considerably more about…
-
Carryover and the ghost peak from last week's standard Replied, post #23 · Analytics › HPLC & UHPLC · 3 Apr 2025 · 0 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Distinguishing a deletion sequence by mass alone Replied, post #49 · Analytics › Mass spectrometry · 4 Feb 2025 · 9 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #27 · Evidence › Meta-analyses · 30 Jan 2025 · 2 likes Post #24 is the version of this I will quote in future. One addition. Taking Random versus fixed effects seriously for a moment rather than deflecting: the honest…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #67 · Analytics › COA interpretation · 27 Jan 2025 · 8 likes Post #63 describes the usual case. This is about the unusual one. Certificates from a supplier's own laboratory are not independent by definition. That is not an…
-
When "no data" is the complete and final answer Replied, post #68 · Compounds › Other compounds · 17 Jan 2025 · 2 likes The tanning compounds carry a specific practical point that is not pharmacological: any change to a pigmented lesion is a reason to see a clinician, and that is not a…
-
Fibre intake when total intake falls, and the constipation link Replied, post #15 · Nutrition & Training › Protein & intake · 9 Jan 2025 · 3 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced. Reading it…
-
Body image changing more slowly than the body Replied, post #114 · Wellbeing › Mental health · 23 Dec 2024 · 1 like Taking body image seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #47 · Sourcing › Regulatory · 5 Dec 2024 · 12 likes A note on scope: what I am saying about Research-use-only labelling applies to the case in the first post and I would not extend it further without checking.
-
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #19 · Practice › Side effects · 26 Nov 2024 · 11 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Revisiting: Moderation log format change Replied, post #37 · Meta › Announcements · 22 Nov 2024 · 13 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #106 · Compounds › Repair & healing peptides · 21 Nov 2024 · 13 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #4 · marked as the solution · Clinical › Special populations · 18 Nov 2024 · 8 likes Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but are being studied. Adolescent physiology and psychology…
-
Buffers, pH and why a formulation is a formulation Replied, post #11 · Pharmacology › Formulation chemistry · 29 Oct 2024 · 1 like Buffer choice affects both solubility and stability, and the two do not always point the same way. A formulation is a compromise between them rather than an optimum for…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #58 · Compounds › Semaglutide · 18 Sep 2024 · 5 likes The bit of c-cell question that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
-
Converting between mg/mL and units per dose, both directions Replied, post #6 · Practice › Reconstitution · 29 Aug 2024 · 5 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Reporting the…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #20 · Analytics › Mass spectrometry · 13 Aug 2024 · 1 like I think the High-resolution question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #19 · Clinical › Prescriber conversations · 12 Jul 2024 · 2 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. That is one dataset and I would not build a rule on it.